Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia 26Lymphoma 19Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 16Burkitt Lymphoma 15Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Graft vs Host Disease 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Chronic-Phase 7Multiple Myeloma 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Juvenile 6Congenital Abnormalities 6Breast Neoplasms 6Blast Crisis 6Neoplasms, Plasma Cell 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Large-Cell, Immunoblastic 5Dendritic Cell Sarcoma, Interdigitating 5Urinary Bladder Neoplasms 4

Interventions

Carboplatin 3Vincristine 2Radiotherapy 2Etoposide 2Cyclophosphamide 2palbociclib 1gadobutrol 1gadobenic acid 1etoposide phosphate 1Yoga 1Topotecan 1Temozolomide 1Surgical Procedures, Operative 1Semaxinib 1Microarray Analysis 1Methotrexate 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Immunohistochemistry 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Gadolinium DTPA 1Filgrastim 1Doxorubicin 1Dexamethasone 1Dasatinib 1Dactinomycin 1Cyproheptadine 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Choroid Plexus Neoplasms × Methotrexate × Clear all
NCT01014767 2019-08-20

Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

Tufts Medical Center

Phase 3 Terminated
27 enrolled 1 chart
CNS

Brain Neoplasms, Choroid Plexus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡